×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
Phase 1 Trial Evaluating MRG-106, a Synthetic Inhibitor of … · 2021. 1. 19. · Phase 1 Trial Evaluating MRG-106, a Synthetic Inhibitor of microRNA-155, in Patients with CTCL EORTC
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form
